Programmed cell death-1/programmed cell death ligand-1 checkpoint inhibitors: differences in mechanism of action
Author:
Affiliation:
1. Department of Thoracic Surgery, Tongji Hospital, Huazhong University of Science & Technology, Wuhan, Hubei, China
2. Department of Oncology, Tongji Hospital, Huazhong University of Science & Technology, Wuhan, Hubei, China
Abstract
Publisher
Future Medicine Ltd
Subject
Oncology,Immunology,Immunology and Allergy
Link
https://www.futuremedicine.com/doi/pdf/10.2217/imt-2018-0110
Reference72 articles.
1. The PD1:PD-L1/2 Pathway from Discovery to Clinical Implementation
2. PD-1 and PD-L1 Checkpoint Signaling Inhibition for Cancer Immunotherapy: Mechanism, Combinations, and Clinical Outcome
3. PD-L2 Expression in Human Tumors: Relevance to Anti-PD-1 Therapy in Cancer
4. Clinicopathologic Analysis of PD-L1 and PD-L2 Expression in Renal Cell Carcinoma: Association with Oncogenic Proteins Status
5. Blockade of Programmed Death-1 Ligands on Dendritic Cells Enhances T Cell Activation and Cytokine Production
Cited by 44 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. The blockage signal for PD-L1/CD274 gene variants and their potential impact on lung carcinoma susceptibility;International Immunopharmacology;2023-12
2. Immune interactions in pembrolizumab (PD-1 inhibitor) cancer therapy and cardiovascular complications;American Journal of Physiology-Heart and Circulatory Physiology;2023-10-01
3. Advancing protein therapeutics through proximity-induced chemistry;Cell Chemical Biology;2023-10
4. Deciphering the roles of aryl hydrocarbon receptor (AHR) in regulating carcinogenesis;Toxicology;2023-08
5. Drug Repurposing for COVID-19 using Computational Methods;Drug Repurposing Against SARS-CoV-2;2023-04-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3